Members Trust CO Amarin Corp Plcuk Transaction History
Members Trust CO
- $2.87 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding AMRN
# of Institutions
154Shares Held
72MCall Options Held
133KPut Options Held
26.4K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$273 Million60.8% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$136 Million9.37% of portfolio
-
Acadian Asset Management LLC Boston, MA3.79MShares$41.6 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY3.4MShares$37.3 Million3.37% of portfolio
-
Morgan Stanley New York, NY2.62MShares$28.8 Million0.0% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $4.43B
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...